Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Kitov Pharma On Sept. 4 Received Notification Letter From Nasdaq Stating Co. Has Regained Compliance

Author: Benzinga Newsdesk | September 08, 2020 06:40am

On September 4, 2020, Kitov Pharma Ltd. (the “Company”) received a notification letter from Nasdaq stating that Nasdaq has determined that for ten consecutive business days (from August 21, 2020 through September 3, 2020), the closing bid price of the Company’s American Depositary Shares (ADSs) has been at $1.00 per ADS or greater, and accordingly, the Company has regained compliance with its minimum bid price for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.

Posted In: KTOV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist